Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesComparison of the Pharmacokinetics of Apricitabine in the Presence and Absence of Ritonavir-Boosted Tipranavir: A Phase I, Open-Label, Controlled, Single-Centre Study
Clinical Drug Investigation, 10/15/09
Cox S et al. – A moderate increase in apricitabine exposure was seen after co–administration with ritonavir–boosted tipranavir but this increase was not of clinical significance. No adjustment of apricitabine dosing is required when administered with ritonavir–boosted tipranavir.
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation
Transplantation Proceedings, 12/16/09
Which drug is effective and safe for acute malaria in pregnancy? Reviewing the evidence
Drug Development Research, 12/16/09
Pharmacokinetic Analysis of Hypoxia 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer
The Journal of Nuclear Medicine, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor